Having trouble accessing articles? Reset your cache.

AS1411: Phase IIb discontinued

Antisoma discontinued an open-label, international Phase IIb trial of AS1411 after early data from about 45 patients showed that the compound was unlikely to show a clear

Read the full 274 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE